The Role of Strain Elastography in Staging Liver Fibrosis
SELF
Usefulness of the Strain Elastography in the Assessment of Liver Fibrosis in Chronic Hepatopathy
1 other identifier
observational
500
1 country
2
Brief Summary
AIM: To evaluate the role of Strain Elastography in the assessment of liver fibrosis in chronic hepatopathy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2014
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 2, 2014
CompletedFirst Posted
Study publicly available on registry
July 8, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedJuly 8, 2014
June 1, 2014
5 months
July 2, 2014
July 2, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Strain Elastography results
Usefulness of strain elastography recordings for the evaluation of liver fibrosis
up to 24 weeks
Study Arms (3)
1. the control group healthy adult volunteers
2. patients with chronic hepatitis B or C
3. pacients with liver cirrhosis type B or C
Eligibility Criteria
The patients included in the study will be healthy voluntaries, patients with chronic hepatitis B or C and patients with liver cirrhosis. ARFI and Hitachi elastography will be performed for each patient and the results will be compared with final diagnosis. The final diagnosis (the stage) will be established based on Transient elastography and or liver biopsy.
You may qualify if:
- age over 18 years old
- Study will include three groups of patients as follows:
- Group I: patients with chronic hepatitis B or C (defined by the presence of serum anti HCV antibody or serum hepatitis B surface antibody)
- Group II (the control group): healthy adult volunteers
- Group III: patients with hepatic cirrhosis type B or C
- There at least one reference method available for patients with chronic hepatitis (Transient elastography/ liver biopsy)
- Hepatic cirrhosis diagnosis is established using clinical and paraclinical features (ultrasonography, superior digestive endoscopy)
- A written informed consent is given to each patient
You may not qualify if:
- Patients with contraindication for elastography (pregnant women or who are breastfeeding) and patients with pacemakers
- Patients with liver disease of other etiology than viral infection (autoimmune hepatitis, primary biliary hepatitis, primary sclerosing cholangitis, hemochromatosis, alfa 1-antitrypsin deficiency, or Wilson's disease)
- History of alcohol abuse (alcohol intake\> 20g/day)
- Patients under treatment with hepatotoxic drugs (methotrexate, amiodarone, corticotherapy , chemotherapy, hormonotherapy)
- Patients with technically unfeasible TE: patients with ascites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Researche Center of Gastroenterology and Hepatology
Craiova, Dolj, 200635, Romania
University of Medicine and Pharmacy
Timișoara, Timiș County, 200635, Romania
Related Publications (5)
Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008 May;48(5):835-47. doi: 10.1016/j.jhep.2008.02.008. Epub 2008 Feb 26.
PMID: 18334275BACKGROUNDde Ledinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010 Aug;30(7):1043-8. doi: 10.1111/j.1478-3231.2010.02258.x. Epub 2010 May 14.
PMID: 20492500BACKGROUNDFriedrich-Rust M, Nierhoff J, Lupsor M, Sporea I, Fierbinteanu-Braticevici C, Strobel D, Takahashi H, Yoneda M, Suda T, Zeuzem S, Herrmann E. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat. 2012 Feb;19(2):e212-9. doi: 10.1111/j.1365-2893.2011.01537.x. Epub 2011 Oct 30.
PMID: 22239521BACKGROUNDKoizumi Y, Hirooka M, Kisaka Y, Konishi I, Abe M, Murakami H, Matsuura B, Hiasa Y, Onji M. Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography--establishment of the method for measurement. Radiology. 2011 Feb;258(2):610-7. doi: 10.1148/radiol.10100319.
PMID: 21273523BACKGROUNDGheonea DI, Saftoiu A, Ciurea T, Gorunescu F, Iordache S, Popescu GL, Belciug S, Gorunescu M, Sandulescu L. Real-time sono-elastography in the diagnosis of diffuse liver diseases. World J Gastroenterol. 2010 Apr 14;16(14):1720-6. doi: 10.3748/wjg.v16.i14.1720.
PMID: 20380003BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adrian Saftoiu, MD, PhD
UMF Craiova
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, MSc Specialist in Gastroenterology
Study Record Dates
First Submitted
July 2, 2014
First Posted
July 8, 2014
Study Start
March 1, 2014
Primary Completion
August 1, 2014
Study Completion
September 1, 2014
Last Updated
July 8, 2014
Record last verified: 2014-06